A detailed history of Imc Chicago, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Imc Chicago, LLC holds 39,792 shares of SAVA stock, worth $93,113. This represents 0.04% of its overall portfolio holdings.

Number of Shares
39,792
Holding current value
$93,113
% of portfolio
0.04%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$9.57 - $35.08 $380,809 - $1.4 Million
39,792 New
39,792 $1.17 Million
Q1 2024

Apr 12, 2024

SELL
$18.44 - $26.41 $21,703 - $31,084
-1,177 Reduced 6.66%
16,484 $334,000
Q4 2023

Feb 09, 2024

BUY
$12.64 - $30.11 $223,235 - $531,772
17,661 New
17,661 $397,000
Q1 2023

Apr 24, 2023

SELL
$23.46 - $36.44 $1.46 Million - $2.26 Million
-62,149 Closed
0 $0
Q4 2022

Feb 09, 2023

BUY
$27.82 - $44.16 $1.73 Million - $2.74 Million
62,149 New
62,149 $1.84 Million
Q2 2022

Aug 05, 2022

SELL
$17.22 - $38.47 $22,954 - $51,280
-1,333 Reduced 11.63%
10,132 $285,000
Q2 2021

Aug 06, 2021

BUY
$32.15 - $89.72 $368,599 - $1.03 Million
11,465 New
11,465 $980,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $93.8M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Imc Chicago, LLC Portfolio

Follow Imc Chicago, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imc Chicago, LLC with notifications on news.